Prospective randomized study to compare imipenem 1.5 grams per day vs. 3.0 grams per day in infections of granulocytopenic patients.

Böhme, A; Shah, P M; Stille, W; Hoelzer, D

Böhme, A; Shah, P M; Stille, W; Hoelzer, D.

Affiliation

Böhme A; Med. Clinic III, Department of Medical Hematology, Johann Wolfgang Goethe-University, Frankfurt, Germany.

J Infect ; 36(1): 35-42, 1998 Jan.

Article in En | MEDLINE | ID: mdl-9515666

Subject(s)

Agranulocytosis/drug therapy; Imipenem/administration & dosage; Thienamycins/administration & dosage; Adolescent; Adult; Aged; Agranulocytosis/classification; Agranulocytosis/economics; Agranulocytosis/microbiology; Female; Humans; Imipenem/adverse effects; Imipenem/economics; Male; Middle Aged; Prognosis; Prospective Studies; Thienamycins/adverse effects; Thienamycins/economics; Treatment Outcome

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Thienamycins / Imipenem / Agranulocytosis Type of study: Clinical_trials / Observational_studies / Prognostic_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Infect Year: 1998 Document type: Article

Search on Google

XML

PubMed Links